Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Ancient moxibustion therapy tested for nocturia relief

NCT ID NCT07598227

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tests whether acupoint moxibustion—a traditional Chinese medicine procedure where a herb is burned near specific points on the body—can safely reduce nighttime urination in adults aged 40 and older who get up to urinate two or more times per night. Researchers will measure changes in how often participants urinate at night and their total nighttime urine volume. The study aims to provide an alternative for those who don't respond well to standard treatments or worry about medication side effects.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
moxibustion (a traditional Chinese medicine procedure where a herb is burned near acupoints)
What this could lead to
If it works, this could offer a non-drug option to reduce nighttime urination and improve sleep quality for people with nocturia.
What could go wrong
This is a small pilot study with no placebo control, so results may not be conclusive. The effect may be small or due to chance, and moxibustion can cause burns or skin irritation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2025

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients aged 40 years or older. * Experiencing two or more nocturia episodes per night. Exclusion Criteria * Active urinary tract infection (UTI). * Poorly controlled diabetes mellitus (defined as HbA1c \> 6.5%). * Presence of a neurogenic bladder caused by conditions such as multiple sclerosis, Parkinson's disease, stroke, spinal cord injury, or nerve damage resulting from major pelvic surgery. * Severe congestive heart failure (New York Heart Association \[NYHA\] functional class \> II). * Use of other Traditional Chinese Medicine (TCM) therapies for nocturia symptoms within the past month (30 days). * Pregnant women.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acupoint are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Nocturia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation

    RECRUITING

    Hualien City, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.